UCF Deciding Brains
Launched by UNIVERSITY OF CENTRAL FLORIDA · Dec 10, 2023
Trial Information
Current as of August 28, 2025
Recruiting
Keywords
ClinConnect Summary
The "UCF Deciding Brains" clinical trial is studying how people make decisions about trust as they age. This research aims to understand how healthy adults, both younger (ages 20-39) and older (60 and above), think about trust and make related choices. If you are a fluent English speaker with at least an 8th-grade education, and you take your medications as prescribed, you may be eligible to participate.
As a participant, you will spend about 3.5 hours in a private room at the University of Central Florida, where you will engage in some computer games and tasks that help researchers learn about your thoughts and experiences. You can take breaks whenever you need them. If you start the study but can’t finish, you will still receive credit for the time you participated. It's important to note that certain medical conditions and medications may exclude you from joining. If you're curious about how trust influences our lives as we age, this study might be a great opportunity for you to contribute to important research!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Younger adults only: Age 20-39 years old
- • Older adults only: Age 60 years old and older
- • Fluent English speaker
- • At least 8th grade education
- • On a stable regimen of medications
- • Able to provide verbal and written informed consent
- • Normal cognitive function
- • Older adults only: The above will be assessed/confirmed via cognitive screening assessments
- • Telephone Interview for Cognitive Status (TICS-M; see "Telephone Interview for Cognitive Status" in Local Site Documents)
- Exclusion Criteria:
- • Pregnant
- * Presence of:
- • Schizophrenia Spectrum or Other Psychotic Disorders
- • Bipolar and Related Disorders
- • Depressive Disorders
- • Anxiety Disorders
- • Trauma- and Stressor-Related Disorders
- • Substance-Related and Addictive Disorders
- • Current anticonvulsant, neuroleptic, or sedative use
- • Uncorrected visual and hearing impairments
- • Neurologic condition or event affecting the brain in the last 12 months (e.g., stroke, epilepsy, traumatic brain injury with \>30-minute loss of consciousness)
- • History of brain surgery including tumor resection, deep brain resection, pallidotomy, and thalamotomy
- • Unstable medical illness (e.g., metastatic cancer)
- • Significant cardiovascular condition or event in the last 12 months (e.g., major heart attack, heart bypass surgery
About University Of Central Florida
The University of Central Florida (UCF) is a leading research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a commitment to excellence in research and education, UCF leverages its diverse expertise and state-of-the-art facilities to conduct cutting-edge studies across various medical disciplines. The university's collaborative approach fosters partnerships with healthcare providers, industry leaders, and community organizations, ensuring that clinical trials are designed to address pressing health challenges while adhering to the highest ethical standards. UCF is dedicated to translating research findings into practical applications that enhance patient care and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Orlando, Florida, United States
Patients applied
Trial Officials
Nichole Lighthall, PhD
Principal Investigator
University of Central Florida
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported